«Off Label Use»: Nouvelles Recommandations

Bulletin des Médecins Suisses
doi 10.4414/bms.2007.12645
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

EMH Swiss Medical Publishers, Ltd.

Related search

Nouvelles Recommandations, Nouvelle Pratique !

Medecine Buccale Chirurgie Buccale
Oral SurgeryPeriodonticsDentistry
2015English

Methylphenidate Off-Label Use and Safety

SpringerPlus
Multidisciplinary
2014English

Off-Label Use of Approved Drugs

Nature Reviews Clinical Oncology
Oncology
2009English

Off-Label Drug Use in Hospitalized Children

Archives of Pediatrics & Adolescent Medicine
2007English

Off-Label Use in Lymphoma Patients in Switzerland

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Off-Label Use of Omalizumab in Pediatric Anaphylaxis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Off-Label Use of Rituximab in Dermatology: Pemphigus Treatment

Anais Brasileiros de Dermatologia
Dermatology
2013English

Reasons for and Frequency of Off - Label Drug Use

Medicinski Pregled
Medicine
2015English

Off-Label Use of Anticancer Drugs in South Korea

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy